On March 31, 2020, Nexien BioPharma, Inc. announced that Alex Wasyl resigned as the chief executive officer and a director of the company due to personal reasons. Richard Greenberg, one of the founders of the company and an existing director, will serve as interim chief executive officer.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0211 USD | -23.68% | -23.83% | -18.53% |
1st Jan change | Capi. | |
---|---|---|
-18.53% | 1.49M | |
+41.96% | 630B | |
-7.15% | 350B | |
+18.77% | 328B | |
+8.79% | 298B | |
+18.02% | 246B | |
+1.27% | 225B | |
+11.95% | 218B | |
+3.68% | 160B | |
-4.38% | 156B |
- Stock Market
- Equities
- NXEN Stock
- News Nexien BioPharma, Inc.
- Nexien BioPharma, Inc. Announces Management Changes